Equity Churn Pushes Up Dabur Pharma

Dabur India LimitedIn early trade, Dabur Pharma was trading up 1.51% to Rs 77.50 after 50 lakh shares changed hands in a single block deal at Rs 76 each on NSE.

The block deal of 50 lakh shares comprised 3.19% of Dabur Pharma's equity. The company has the equity capital of Rs 15.67 crore, with 15.97 crore outstanding shares having face values of Rs 1 each.

During the day, the scrip touched a high peak of Rs 79.40 and a low of Rs 76.40. Today, there were 12,777 for trading on the BSE counter. In the last one quarter, the scrip showed an average daily volume of 52,869 shares. At its existing price of Rs 77.50, the scrip trades at a PE multiple of 48.13, which is based on ear ended march 2007 earning per share (EPS) of Rs 1.61.

In one month to 3 july 2007, the scrip gained 6.89% against the Sensex’s 2.14% return. In the last three months, it appended 12.78% as compared to the Sensex’s increase of 15.80%. On 9 January 2007, the stock has had its yearly high of Rs 86.30, and an yearly low of Rs 51 on 19 July 2006.

Dabur Pharma’s net profit had surged 1,200% to Rs 2.73 crore in Q4 March 2007 as against Rs 0.21 crore in Q4 March 2006. Sales moved up 16.3% to Rs 57.73 crore in Q4 March 2007 (Rs 49.62 crore).

Dabur Pharma is the leading the Indian market in the oncology segment and various major Asian markets such as Malaysia and Thailand where the company is pitted against global pharma majors.




Check out More news from Telecom Sector :: Pharmaceutical Sector :: Auto Sector :: Infrastructure :: Real Estate